Article

PresbyLASIK reduces need for glasses in presbyopic patients, according to study

PresbyLASIK, an advanced form of LASIK developed to correct presbyopia, may reduce the need for glasses for middle-aged patients, according to research.

McHenry, IL-PresbyLASIK, an advanced form of LASIK developed to correct presbyopia, may reduce the need for glasses for middle-aged patients, according to research.

In a study led by Robert L. Epstein, MD, Mercy Center for Corrective Eye Surgery, McHenry, IL, the need for glasses was eliminated for 92% of middle-aged patients and the effect was proven to last beyond 2 years. Patients averaged 53 years of age and initially were wearing bifocals and reading glasses.

The group has 6 years of follow up on the presbyLASIK technique, and Dr. Epstein reported that 99% of their previously bifocal-bound patients became completely or nearly fully out of glasses.

PresbyLASIK also applies to people who had cataract surgery, and variations of the new technology also can help some people who are not LASIK candidates, according to Dr. Epstein.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) Inside NYEE’s new refractive solutions center with Kira Manusis, MD
(Image credit: Ophthalmology Times) Dilsher Dhoot, MD, on the evolution of geographic atrophy therapy: where are we now?
(Image credit: Ophthalmology Times Europe) Anat Loewenstein, MD, shares insights on the real-world results of remote retinal imaging
(Image credit: Ophthalmology Times) Two-wavelength autofluorescence for macular xanthophyll carotenoids with Christine Curcio, PhD
(Image credit: Ophthalmology Times) FLIO and the brain: Making the invisible visible with Robert Sergott, MD
(Image credit: Ophthalmology Times) Structure-function correlates using high-res OCT images with Karl Csaky, MD, PhD
(Image credit: Ophthalmology Times) SriniVas Sadda, MD, on high-res OCT of atrophic and precursor lesions in AMD
(Image credit: Ophthalmology Times) Christine Curcio, PhD, shares histology update supporting review software and revised nomenclature for <3 μm OCT
1 expert is featured in this series.
© 2025 MJH Life Sciences

All rights reserved.